Comparison of two breathing devices for patients undergoing Abdominal surgeries.

Assessment of the clinical performance of AMBU Auragain vs Endotracheal Intubation for patients undergoing laparoscopic surgery - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082286

Enrollment

Registered

2025-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Endotracheal intubation, supraglottic airway insertion: Endotracheal intubation using ET tubes, AMBU Auragain supraglottic airway insertion. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II , planned for elective Laparoscopic surgeries in reverse Trendelenberg position

Exclusion criteria

Exclusion criteria: BMI of more than 35 kgs/m2 , Abdominal mass, pregnancy, patients with GERD, patients with anticipated difficult airway ( MPG grade III and grade IV )

Design outcomes

Primary

Measure	Time frame
Cuff pressure measurement of Endotracheal tube and AMBU Auragain .Timepoint: 1) After cuff inflation 2) After CO2 insufflation 3) Before CO2 desufflation	—

Secondary

Measure	Time frame
Systolic BP, Diastolic BP, Mean arterial pressureTimepoint: Baseline Before airway insertion During airway insertion After 10 min After 20 min After 30 min After 40 min After 50 min After 60 min;Presence or absence of sore throatTimepoint: 2 hrs Before surgery 6 hrs After surgery	—

Countries

India

Contacts

Public ContactDr. Jitendra Kumar

Gandhi Medical College and Hamidia hospital

vdrtripti@gmail.com9827012052

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026